Clinical Trials on High Blood Cholesterol Level in Switzerland

Total 19 results

Novartis Pharmaceuticals

Completed

Adherence and Persistence to Inclisiran Among Early Users in Germany

High Levels of Low-density Lipoprotein Cholesterol

Switzerland
University Hospital, Basel, Switzerland

Completed

Cytosorb Therapy in Cardiac Surgery

Endocarditis | Cardiopulmonary Surgery | Peri-operative Cytokines Levels

Switzerland
University Hospital Inselspital, Berne
Edwards Lifesciences

Completed

Pulse Contour Analysis and Tissue Oxymetry in Changing Vascular Tone

Vasodilation | Vasoconstriction | Hemodynamics | Cardiac Output, Low | Cardiac Output, High

Switzerland
Edwards Lifesciences

Completed

Using Minimally Invasive Cardiac Output Data vs. Standard Care for Patients Emergently Admitted to the Intensive Care Unit Who Are Hemodynamically Unstable

Cardiac Output, Low | Cardiac Output, High

Switzerland, Finland
Urs E. Nydegger
Labormedizinisches Zentrum Dr. Risch

Unknown

Impact of Oral Glucose Tolerance Test on Extent of Hemoglobin Glycation (HbA1c)

Blood Glucose, High | Oral Hypoglycaemic Overdose

Switzerland
University Hospital Inselspital, Berne

Completed

Pedometer Activity Monitoring After ASCT (PAMAL)

Lymphoma | Myeloma | Autologous Stem Cell Transplantation | High-dose Chemotherapy

Switzerland
University of Zurich

Completed

Altitude Related Adverse Health Effects (ARAHE) in Patients With Precapillary Pulmonary Hypertension During 30h Exposure to 2500m

High Altitude Pulmonary Hypertension

Switzerland
University of Zurich

Completed

Exercise Endurance Time on the 2nd Day at 2500 m High Altitude

High Altitude Pulmonary Hypertension

Switzerland
University of Zurich

Completed

Nocturnal Oxygenation and Sleep-related Breathing Disorders During the First Night of a Stay at 2500m of High Altitude in Patients With Precapillary Pulmonary Hypertension

Sleep | High Altitude Pulmonary Hypertension

Switzerland
University of Zurich

Completed

Effect of Oxygen Therapy for Patients With Precapillary Pulmonary Hypertension Who Experience an Altitude Related Adverse Health Effect (ARAHE) During 30h Exposure to 2500m

Oxygen Therapy | High Altitude Pulmonary Hypertension

Switzerland
University Hospital, Basel, Switzerland

Completed

The Circadian Rhythm of Copeptin (Co-Rhythm)

Circadian Rhythm | Copeptin Blood Levels

Switzerland
University of Zurich

Completed

Maximal Exercise Capacity at 2500 m of High Altitude

High Altitude Pulmonary Hypertension | Maximal Exercise Capacity

Switzerland
Novartis Pharmaceuticals

Terminated

Phase III Study Investigating the Efficacy and Safety of Ruxolitinib in Early Myelofibrosis Patients With High Molecular Risk Mutations. (ReTHINK)

Myelofibrosis With High Molecular Risk Mutations

Belgium, Spain, United Kingdom, Hungary, Italy, Japan, Taiwan, Germany, Canada, Singapore, Austria, Australia, France, Israel, Sweden, Switzerland, Hong Kong, Greece, Turkey, Brazil, Russian Federation, Denmark, Portugal, Norway, Poland
La Jolla Pharmaceutical Company

Completed

A Phase 3 Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension (ATHOS-3)

Sepsis | Catecholamine-resistant Hypotension (CRH) | Distributive Shock | High Output Shock

United States, Canada, Belgium, Australia, United Kingdom, Finland, New Zealand, France, Switzerland, Germany
ECRI bv
University of Bern; European Cardiovascular Research Center; Terumo Medical Corporation and other collaborators

Completed

Management of High Bleeding Risk Patients Post Bioresorbable Polymer Coated Stent Implantation With an Abbreviated Versus Prolonged DAPT Regimen (MASTER DAPT)

Coronary Artery Disease | PCI | High Bleeding Risk

Netherlands, France, United Kingdom, Australia, Singapore, Japan, Italy, Poland, Spain, Switzerland, Israel, Argentina, Austria, Bahrain, Bangladesh, Belgium, Bulgaria, Czechia, Denmark, Estonia, Germany, Hungary, India, Korea, Republic... and more
Ablynx, a Sanofi company

Completed

Comparative Study of ALX-0081 Versus GPIIb/IIIa Inhibitor in High Risk Percutaneous Coronary Intervention (PCI) Patients

Unstable Angina | Non ST Segment Elevation Myocardial Infarction (NSTEMI) | Stable Angina (Associated With High Risk PCI)

Poland, Belgium, Germany, Israel, Austria, Switzerland, Czechia
Amgen

Terminated

Effect of Blinatumomab on Minimal Residual Disease (MRD) in Diffuse Large B-Cell Lymphoma (DLBCL) Subjects Post Autologous Hematopoietic Stem Cell Transplantation (aHSCT)

High-risk Diffuse Large B-cell Lymphoma

United States, Italy, Belgium, Switzerland, Australia, France, Greece
MEI Pharma, Inc.

Terminated

A Study of ME-401 in Subjects With CLL/SLL, FL, and B-cell Non Hodgkin's Lymphoma

Chronic Lymphocytic Leukemia (CLL) | Small Lymphocytic Lymphoma (SLL) | Mantle Cell Lymphoma (MCL) | Diffuse Large B-cell Lymphoma (DLBCL) | Follicular Lymphoma (FL) | Marginal Zone B Cell Lymphoma | High Grade Non-Hodgkin's Lymphoma

United States, Switzerland
Bayer

Recruiting

A Study to Test Asundexian for Preventing a Stroke Caused by a Clot in Participants After an Acute Ischemic Stroke or After a High-risk Transient Ischemic Attack, a So-called Mini Stroke (OCEANIC-STROKE)

Acute Non-cardioembolic Ischemic Stroke | Prevention of Ischemic Stroke | High-risk Transient Ischemic Attack

United States, Switzerland, Belgium, Sweden, Canada, Australia, Taiwan, Spain, Korea, Republic of, Latvia, Israel, Malaysia, Greece, Japan, Turkey, Netherlands, Romania, China, United Kingdom, Portugal, Italy, France, Slovakia, Austria, Czechi... and more

Clinical Trials on High Blood Cholesterol Level in Switzerland

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Georgia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations